The 2024 data shows pronounced variation in per capita healthcare expenditure on pharmaceuticals and medical non-durable goods across Europe. Malta leads with the highest expenditure at 224.03 euros per capita, followed by Switzerland and France. Year-on-year changes indicate substantial growth in Malta (17.03%), Switzerland (8.22%), and Lithuania (22.86%), while declines are observed in the Netherlands (-9.47%) and Portugal (-6.96%). Over the last two years, the expenditure has generally increased, with varied trends among countries, reflecting differing healthcare priorities and economic conditions.
Future trends may include:
- Possible increase in digital health adoption influencing spending patterns.
- Shifting demographics and aging populations impacting pharmaceutical demands.
- Potential policy changes in healthcare expenditure as European countries navigate economic challenges and healthcare innovations.
Top countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Hospitals by Country
# | 10 Countries | Euros Per Capita | Last Year | YoY | 5-years CAGR | |
---|---|---|---|---|---|---|
1 | 1 Malta | 224.03 | 2023 | +8.87% | +17.03% | View data |
2 | 2 Switzerland | 160.76 | 2023 | +5.68% | +8.22% | View data |
3 | 3 France | 116.96 | 2023 | +4.84% | +5.66% | View data |
4 | 4 Luxembourg | 107.6 | 2023 | +5.6% | +7.1% | View data |
5 | 5 Italy | 88.27 | 2023 | +1.65% | +3.13% | View data |
6 | 6 Belgium | 69.99 | 2023 | +2.37% | +8.24% | View data |
7 | 7 Cyprus | 44.5 | 2023 | +12.83% | -0.99% | View data |
8 | 8 Czech Republic | 33.25 | 2023 | +2.66% | +0.26% | View data |
9 | 9 Ireland | 12.21 | 2023 | +14.11% | +4.16% | View data |
10 | 10 Latvia | 6.08 | 2023 | +3.93% | +7.22% | View data |